<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04881149</url>
  </required_header>
  <id_info>
    <org_study_id>CYN20-FIRM-LIPO-ROLLOVER</org_study_id>
    <nct_id>NCT04881149</nct_id>
  </id_info>
  <brief_title>Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks</brief_title>
  <official_title>Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate histological results of the treatments with the&#xD;
      TempSure Firm handpiece on the flanks performed in the CYN20-FIRM-LIPO study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 10 subjects will be enrolled at up to 3 study centers. Subjects will receive 2&#xD;
      biopsies, 1 biopsy in the treatment area (the flanks) and 1 biopsy outside of the treatment&#xD;
      area to serve as a control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 9, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Skin Biopsies</measure>
    <time_frame>1 Week (7-10 days) Post Baseline</time_frame>
    <description>Sections of skin will be removed using the punch biopsy technique to render a microscopic diagnosis. Each specimen will first be preserved with a fixative and then stained using Hemotoxylin &amp; Eosin, Verhoeff and Masson Red/Fast Green and/or nitroblue tetrazolium chloride (NBTC) staining methods. If using Hemotoxylin &amp; Eosin, Verhoeff and Masson Red/Fast Green staining, samples will be assessed and evaluated by the amount of collagen and elastin stained. If using NBTC staining, samples will be assessed and evaluated to differentiate between the blue-stained viable cells and the unstained thermally damaged cells</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Skin Laxity</condition>
  <arm_group>
    <arm_group_label>TempSure Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The TempSure will be used on the flanks during this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TempSure treatment</intervention_name>
    <description>Self-controlled, single-arm study using the TempSure device.</description>
    <arm_group_label>TempSure Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        â€¢ Subject has completed their participation in the CYN20-FIRM-LIPO study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The subject has not had any other treatment in the treatment area after their&#xD;
             involvement in the CYN20-FIRM-LIPO study.&#xD;
&#xD;
          -  The subject has any condition or is in a situation which in the investigators opinion&#xD;
             may put the subject at significant risk, may confound study results or may interfere&#xD;
             significantly with the subject's participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Civiok</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>JUVA Skin &amp; Laser Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>May 4, 2021</study_first_submitted>
  <study_first_submitted_qc>May 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

